A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and Sarcopenia
Clinical trial NCT04874350 · COMPLETED
Trial details
- NCT number
- NCT04874350
- Sponsor
- Lipocine Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-30
- Primary completion
- 2023-12-18
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.